ZFGN Insider Trading Activity and SEC Form 4 Filings
ZFGN insider trading summary
No open-market insider purchases or sales of Zafgen, Inc. (ZFGN) have been reported on SEC Form 4 in the past 12 months.
Latest ZFGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 28, 2018 | Thomas E. Hughes | See Remarks | Sell | $320K (32,000 @ $10.00) |
| Mar 7, 2018 | Thomas E. Hughes | See Remarks | Sell | $50K (5,000 @ $10.00) |
| Oct 13, 2017 | Frances K Heller | Director | Buy | $39K (10,000 @ $3.90) |
| Jul 11, 2017 | Dennis D Kim | Chief Medical Officer | Buy | $34K (10,000 @ $3.39) |
| May 11, 2017 | Dennis D Kim | Chief Medical Officer | Buy | $43K (9,800 @ $4.40) |
| May 10, 2017 | Dennis D Kim | Chief Medical Officer | Buy | $880 (200 @ $4.40) |
| Dec 19, 2016 | Frances K Heller | Director | Buy | $32K (10,000 @ $3.23) |
| Nov 15, 2016 | Frances K Heller | Director | Buy | $35K (10,000 @ $3.54) |
| Aug 29, 2016 | Thomas E. Hughes | President and CEO | Buy | $30K (10,000 @ $3.00) |
| Jul 26, 2016 | Patricia L Allen | Chief Financial Officer | Buy | $26K (8,200 @ $3.15) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.